MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0029088
Market Cap
₹43.82 Cr
KMSMEDI · BSE
Share Price
₹132.80
0.00% today
Revenue
₹12.21 Cr
FY 2025-26 · -12.4% YoY
EBITDA
₹0.94 Cr
Margin 7.7%
Net Profit
₹0.25 Cr
FY 2025-26 · -41.9% YoY
P/E (TTM)
99.6x
P/B 5.4x
ROE
3.0%
ROCE 5.2%
Debt / Equity
0.10
Interest cover 29.8x
About KMS Medisurgi Limited
Data last updated:
KMS Medisurgi Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 25 March 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L51397MH1999PLC119118. Its GSTIN is 27AAACK9269Q1ZM (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 540468.
The company has an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3.3 Cr. It was formerly known as Kms Medisurgi Private Limited. It is led by directors including Siddharth Gaurang Kanakia (Managing Director) and Pratik Pravin Tarpara.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 297/301 May Building Gr. Floor Marine Lines(East) Princess Street, Mumbai, Maharashtra, India – 400002.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹12.21 Cr, a decline of 12.4% compared to the previous year. For the same year it recorded a net profit of ₹25 Lakh (net margin 2%) and EBITDA of ₹94 Lakh (EBITDA margin 7.7%). The net worth stands at ₹8.31 Cr (up 2.7% YoY). Total assets are valued at ₹9.09 Cr (up 1% YoY).
The company is associated with 1 brand: KMS Group. As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹2.65 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending. The company has 16 deals on record (15 market trades, 1 ipo); the latest was in September 2025. The company has 8 MSME Form 1 returns on record between 2021 and 2023, listing 24 overdue payments to 9 micro and small suppliers.
KMS Medisurgi Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0029088). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kmsgroup.in.
Company details
CIN L51397MH1999PLC119118
Registration Number 119118
Incorporation Date 25 March 1999
ROC Mumbai
Listing Status Listed - Listed on BSE (540468)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0029088
CIN history
KMS Medisurgi has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L51397MH1999PLC119118, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51397MH1999PLC119118 | Current |
| U51397MH1999PLC119118 | Previous |
| U51397MH1999PTC119118 | Previous |
Key People
Siddharth Gaurang Kanakia Managing Director Pratik Pravin Tarpara Director Kamlesh Chunilal Rajani Director Recognitions & Rankings of KMS Medisurgi
Contact details
KMS Medisurgi Limited's registered office is in Mumbai, Maharashtra. Its website is kmsgroup.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address297/301 May Building Gr. Floor Marine Lines(East) Princess Street, Mumbai, Maharashtra, India – 400002
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of KMS Medisurgi Limited, buy the company report.
Comprehensive company report
KMS Medisurgi Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
KMS Medisurgi operates one associated brand: KMS Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Surgical adhesive tapes and wound dressings are developed by KMS. | kmsgroup.in |
Business activity
The main business activity of KMS Medisurgi is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of KMS Medisurgi Limited, buy the company report.
Financials of KMS Medisurgi Limited
FY 2025-26 filings availableKMS Medisurgi Limited reported revenue of ₹12.21 Cr (down 12.4% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹12.21 Cr
-12.4% YoY
EBITDA
₹0.94 Cr
0.0% YoY
Profit After Tax
₹0.25 Cr
-41.9% YoY
Net Worth
₹8.31 Cr
+2.7% YoY
Total Assets
₹9.09 Cr
+1.0% YoY
Total Debt
₹0.77 Cr
-15.4% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 12.21 | 13.94 | 13.88 | 11.03 | 10.32 | 7.51 | 10.34 |
| Revenue growth | -12.4% | +0.4% | +25.8% | +6.9% | +37.4% | -27.4% | - |
| EBITDA | 0.94 | 0.94 | 0.78 | 0.98 | 0.53 | 0.51 | 0.65 |
| EBITDA margin | +7.7% | +6.7% | +5.6% | +8.9% | +5.1% | +6.8% | +6.3% |
| Profit before tax | 0.34 | 0.60 | 0.60 | 0.68 | 0.29 | 0.25 | 0.17 |
| Net profit | 0.25 | 0.43 | 0.49 | 0.59 | 0.22 | 0.14 | 0.10 |
| Net profit margin | +2.1% | +3.1% | +3.5% | +5.4% | +2.1% | +1.9% | +1.0% |
| EPS (₹) | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Balance sheet | |||||||
| Total assets | 9.09 | 9.00 | 8.20 | 8.22 | 7.66 | 7.48 | 7.45 |
| Net worth | 8.31 | 8.09 | 7.66 | 7.23 | 6.67 | 6.45 | 6.35 |
| Total debt | 0.77 | 0.91 | 0.54 | 0.99 | 0.99 | 1.03 | 1.11 |
| Cash & bank | 1.10 | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 |
| Net working capital | 5.86 | 5.97 | 6.28 | 6.22 | 6.07 | 5.82 | 5.64 |
| Cash flow | |||||||
| Cash from operations | 1.51 | 0.74 | 1.21 | 0.46 | (0.07) | 0.53 | (0.84) |
| Cash from investing | (0.61) | (0.96) | (0.51) | (0.66) | (0.12) | (0.10) | 0.01 |
| Cash from financing | (0.26) | 0.27 | (0.47) | (0.01) | (0.02) | (0.11) | (0.06) |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 12.21 | 13.94 | 13.88 | 11.03 | 10.32 | 7.51 | 10.34 |
| Revenue growth | -12.4% | +0.4% | +25.8% | +6.9% | +37.4% | -27.4% | - |
| Other income | 0.01 | 0.03 | 0.09 | 0.02 | 0.05 | 0.10 | 0.00 |
| Total expenses | 11.27 | 13.00 | 13.10 | 10.05 | 9.79 | 7.00 | 9.69 |
| Employee cost | 1.16 | 1.05 | 1.17 | 0.96 | 0.79 | 0.68 | 0.76 |
| EBITDA | 0.94 | 0.94 | 0.78 | 0.98 | 0.53 | 0.51 | 0.65 |
| EBITDA margin | +7.7% | +6.7% | +5.6% | +8.9% | +5.1% | +6.8% | +6.3% |
| Depreciation | 0.47 | 0.27 | 0.25 | 0.32 | 0.29 | 0.33 | 0.41 |
| Interest | 0.14 | 0.10 | 0.02 | 0.00 | 0.00 | 0.03 | 0.07 |
| Profit before tax | 0.34 | 0.60 | 0.60 | 0.68 | 0.29 | 0.25 | 0.17 |
| Tax | 0.09 | 0.17 | 0.15 | 0.09 | 0.07 | 0.11 | 0.07 |
| Net profit | 0.25 | 0.43 | 0.49 | 0.59 | 0.22 | 0.14 | 0.10 |
| Net profit margin | +2.1% | +3.1% | +3.5% | +5.4% | +2.1% | +1.9% | +1.0% |
| EPS (₹) | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves & surplus | 5.01 | 4.79 | 4.36 | 3.93 | 3.37 | 3.15 | 3.05 |
| Shareholders' funds (net worth) | 8.31 | 8.09 | 7.66 | 7.23 | 6.67 | 6.45 | 6.35 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.13 |
| Unsecured loans | 0.77 | 0.91 | 0.54 | 0.99 | 0.99 | 0.98 | 0.98 |
| Total debt | 0.77 | 0.91 | 0.54 | 0.99 | 0.99 | 1.03 | 1.11 |
| Total liabilities | 9.09 | 9.00 | 8.20 | 8.22 | 7.66 | 7.48 | 7.45 |
| Assets | |||||||
| Gross block | 7.26 | 5.54 | 5.24 | 5.93 | 5.27 | 5.15 | 4.98 |
| Net block | 2.93 | 1.68 | 1.65 | 1.82 | 1.48 | 1.65 | 1.81 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 2.54 | 2.52 | 2.09 | 0.92 | 0.97 | 0.67 | 1.35 |
| Sundry debtors | 3.22 | 4.24 | 5.78 | 6.54 | 6.54 | 6.28 | 5.50 |
| Cash & bank balances | 1.10 | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 |
| Loans & advances | 0.46 | 0.08 | 0.64 | 0.08 | 0.33 | 0.12 | 0.15 |
| Total current assets | 7.32 | 7.31 | 8.93 | 7.73 | 8.24 | 7.68 | 7.29 |
| Total current liabilities | 1.46 | 1.34 | 2.65 | 1.51 | 2.17 | 1.86 | 1.65 |
| Net working capital | 5.86 | 5.97 | 6.28 | 6.22 | 6.07 | 5.82 | 5.64 |
| Total assets | 9.09 | 9.00 | 8.20 | 8.22 | 7.66 | 7.48 | 7.45 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 | 1.18 |
| Net cash from operating activities | 1.51 | 0.74 | 1.21 | 0.46 | (0.07) | 0.53 | (0.84) |
| Net cash from investing activities | (0.61) | (0.96) | (0.51) | (0.66) | (0.12) | (0.10) | 0.01 |
| Net cash from financing activities | (0.26) | 0.27 | (0.47) | (0.01) | (0.02) | (0.11) | (0.06) |
| Net change in cash | 0.64 | 0.05 | 0.23 | (0.21) | (0.21) | 0.32 | (0.88) |
| Closing cash | 1.10 | 0.47 | 0.42 | 0.19 | 0.40 | 0.61 | 0.29 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -12.4% | +0.4% | +25.8% | +6.9% | +37.4% | -27.4% | - |
| EBITDA growth | 0.0% | +20.5% | -20.4% | +84.9% | +3.9% | -21.5% | - |
| PBT growth | -43.3% | 0.0% | -11.8% | +134.5% | +16.0% | +47.1% | -15.0% |
| Net income growth | -41.9% | -12.2% | -17.0% | +168.2% | +57.1% | +40.0% | - |
| Revenue CAGR (3Y) | +3.5% | +10.5% | +22.7% | +2.2% | +1.5% | +0.9% | +9.4% |
| EBITDA CAGR (3Y) | -1.4% | +21.1% | +15.2% | +14.7% | +20.9% | +2.8% | -11.3% |
| Profitability & leverage | |||||||
| Net income margin | +2.1% | +3.1% | +3.2% | +5.4% | +2.1% | +1.9% | +1.0% |
| Return on capital employed | +5.2% | +8.3% | +7.6% | +8.3% | +3.8% | +3.5% | +3.4% |
| Return on net worth | +3.1% | +5.6% | +6.0% | +8.2% | +3.4% | +1.9% | +1.8% |
| Debt / equity | 0.10 | 0.09 | 0.10 | 0.14 | 0.15 | 0.17 | 0.18 |
| Long-term debt / equity | 0.10 | 0.09 | 0.10 | 0.14 | 0.15 | 0.17 | 0.18 |
| Interest cover | 29.79 | 14.93 | 3.77 | 0.00 | 0.00 | 16.67 | 29.17 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.91 | 2.59 | 2.49 | 1.97 | 1.98 | 1.48 | 2.08 |
| Inventory turnover | 4.83 | 6.05 | 9.22 | 11.67 | 12.59 | 7.44 | 6.54 |
| Debtors turnover | 3.27 | 2.78 | 2.25 | 1.69 | 1.61 | 1.28 | 1.96 |
| EPS (₹) | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Dividend per share (₹) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Book value per share (₹) | 25.20 | 24.50 | 23.22 | 21.89 | 20.21 | 19.56 | 19.23 |
To see the full year-wise statements and ratios of KMS Medisurgi Limited, buy the company report.
Board of directors of KMS Medisurgi Limited
KMS Medisurgi has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Gaurang Kanakia Also directs: KMS Manufacturing Limited, KMS Comtrade Private Limited | Managing Director | 02 May 2018 | 8 Years 6 Months | Current |
| Pratik Pravin Tarpara | Director | 12 Feb 2020 | 6 Years 8 Months | Current |
| Kamlesh Chunilal Rajani | Director | 11 Aug 2016 | 10 Years 2 Months | Current |
| Hardik Rajnikant Bhatt | Director | 14 Jul 2016 | 10 Years 3 Months | Current |
| Rohan Devang Kanakia | Director | 29 Jun 2021 | 5 Years 4 Months | Current |
| Gaurang Prataprai Kanakia Also directs: KMS Manufacturing Limited, Dermacare Surgicals Private Limited, Moni Diamonds Limited and 1 more | Director | 03 May 2023 | 3 Years 6 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
KMS Medisurgi Limited is audited by Dalal Doctor & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Dalal Doctor & Associates | FY 2023 | 120833W |
Shareholding
Shareholding for the quarter ended Jun 2026: promoters hold 74.40%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 25.60%.
Jun 2026
QUARTER
74.40% Promoters
25.60% Retail & Others
Promoter holding - history
Now 74.40% · Jun 2026High 74.40% · Sep 2025Low 74.40% · Sep 2025
Shareholding trend - last 6 quarters
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | |
|---|---|---|---|---|
| Promoters | 74.40% | 74.40% | 74.40% | 74.40% |
| Public | 25.60% | 25.60% | 25.60% | 25.60% |
Charges & borrowings
Open charges
₹4 Cr
Satisfied charges
₹2.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Sep 2018 | 100210249 | Others | ₹4 Cr | Open | |
| 18 Mar 2014 | 10486159 | Union Bank of India | ₹25 Lakh | Satisfied | |
| 16 Jan 2003 | 80066450 | Union Bank of India | ₹2.35 Cr | Satisfied | |
| 16 Jan 2003 | 80066451 | Union Bank of India | ₹5 Lakh | Satisfied |
To see the full charge records of KMS Medisurgi Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
KMS Medisurgi Limited has 16 deals on record (15 market trades, 1 ipo); the latest was in September 2025.
Total deals
16
Market trades
15
IPO
1
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2025 | Market trade | ₹34.2 Lakh | Buyer: an individual |
| Jun 2025 | Market trade | ₹95.8 Lakh | Buyer: an individual Seller: Meghna Infracon Infrastructure Limited |
| Feb 2020 | Market trade | ₹14.8 Lakh | Buyer: Kindle Broking Private Limited Seller: an individual |
| Feb 2020 | Market trade | ₹2.22 Cr | Buyer: Alacrity Securities Limited , Naysaa Seurities Limited, 2 individuals Seller: Naysaa Seurities Limited, Alacrity Securities Limited , B B Commercial Ltd , an individual |
| Apr 2017 | Market trade | ₹24.4 Lakh | Buyer: Motive Broking & Advisory Private Limited |
To see the full deal history of KMS Medisurgi Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
KMS Medisurgi Limited has 3 court cases on record: 2 filed by KMS Medisurgi, 1 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (CUAPP) | Filed against the company by Commissioner of Customs Imports | Pending |
| District court, Central, Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against The Commissioner Health and Family Welfare and 2 others | Disposed |
To see the full case history of KMS Medisurgi Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
KMS Medisurgi Limited has 8 MSME Form 1 returns on record between 2021 and 2023, listing 24 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Jaimaa Industrial Coatings Private Limited | |||
| Loparex India Private Limited | |||
| Auraa Adhesive Tapes Private Limited | |||
| Perfect Packaging |
To see the full MSME payment records of KMS Medisurgi Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
KMS Medisurgi has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK9269Q1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of KMS Medisurgi Limited, buy the company report.
Recent activity
KMS Medisurgi Limited has 20 board changes on record since 2003: 14 appointments and 6 cessations. The latest: Pavan Kumar Gupta ceased to be Company Secretary on 31 Mar 2025.
Filing
Kms Medisurgi Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai I.
AGM
Kms Medisurgi Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Pavan Kumar Gupta ceased to be Company Secretary.
Charges
A charge with Others of Rs. 4.00 Cr registered on 28 Sep 2018 with Charge ID 100210249 was modified on 20 Aug 2024.
Appointed
Pavan Kumar Gupta was appointed as Company Secretary.
Appointed
Gaurang Prataprai Kanakia was appointed as Director.
Appointed
Monali Gaurang Kanakia was appointed as Director.
Ceased
Rekha Devang Kanakia ceased to be Managing Director.
Ceased
Mariam Khalil Bahnan ceased to be Company Secretary.
Appointed
Rohan Devang Kanakia was appointed as Director.
Appointed
Mariam Khalil Bahnan was appointed as Company Secretary.
Appointed
Pratik Pravin Tarpara was appointed as Director.
20 earlier events are in the company report.
Frequently asked questions
KMS Medisurgi is an active public limited company based in Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 25 March 1999 (27+ years old) and is registered under CIN L51397MH1999PLC119118. Listed on BSE: 540468.
KMS Medisurgi reported revenue of ₹12.21 Cr for FY 2025-26 (down 12.4% YoY) based on standalone financials.
KMS Medisurgi has 7 current directors:
- Siddharth Gaurang Kanakia - Managing Director
- Pratik Pravin Tarpara - Director
- Kamlesh Chunilal Rajani - Director
- Hardik Rajnikant Bhatt - Director
- Rohan Devang Kanakia - Director
- Gaurang Prataprai Kanakia - Director
- Monali Gaurang Kanakia - Director
The latest financial statements of KMS Medisurgi on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of KMS Medisurgi is 27AAACK9269Q1ZM, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of KMS Medisurgi is L51397MH1999PLC119118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. KMS Medisurgi is a listed company as per MCA records. Its shares are listed on BSE (code: 540468).
KMS Medisurgi has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
KMS Medisurgi was incorporated on 25 March 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
KMS Medisurgi has 16 deals on record (15 market trades, 1 ipo); the latest was in September 2025.
Pavan Kumar Gupta ceased to be Company Secretary on 31 Mar 2025. Pavan Kumar Gupta was appointed as Company Secretary on 23 May 2024. Gaurang Prataprai Kanakia was appointed as Director on 03 May 2023. KMS Medisurgi has 20 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages